📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Samsung Biologics Co Ltd
Samsung Biologics's GHG Emissions Data Preview
In 2024, Samsung Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Samsung Biologics has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Samsung Biologics’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Samsung Biologics’s data sources below and access millions more through our Disclosure Search.
Insights into Samsung Biologics's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofSamsung Biologics amounted to233,709.069metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Samsung Biologicsincreased by 6.38%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
Samsung Biologics's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Samsung Biologics's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Samsung Biologics were 71,971.718 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Has Samsung Biologics reduced its Scope 1 emissions over time?
Since 2019, Samsung Biologics's Scope 1 emissions have increased by 73.56%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year(2023), Samsung Biologics's Scope 1 emissions increased by 3.91%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
What are Samsung Biologics's Scope 2 emissions?
In 2024, Samsung Biologics reported Scope 2 greenhouse gas (GHG) emissions of 115,827.854 tCOâ‚‚e using the market-based method and 161,737.351 tCOâ‚‚e using the location-based method.a
Has Samsung Biologics reduced its Scope 2 emissions over time?
Compared to the previous year(2023), Samsung Biologics's Scope 2 emissions(Location-Based) have remained relatively stable, indicating that Samsung Biologics's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does Samsung Biologics use for Scope 2 reporting?
In 2024, Samsung Biologics reported its Scope 2 emissions using the market-based method and using the location-based method.a
Samsung Biologics's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into Samsung Biologics's Value Chain Emissions
In 2024, Samsung Biologics reported 448,410.157 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Samsung Biologics includes a breakdown across 11of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
Samsung Biologics's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Samsung Biologics's Scope 3 emissions?
In 2024, Samsung Biologics reported total Scope 3 emissions of 448,410.157 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 91.89%of these emissions originated from upstream activities such as purchased goods and capital goods, while 8.11%came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2023), Samsung Biologics's Scope 3 emissions decreased by 12.73%, highlighting the company's efforts to lower indirect emissions from its value chain.a
What categories of Scope 3 emissions does Samsung Biologics disclose?
In 2024, Samsung Biologics reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Samsung Biologics's Scope 3 emissions?
In 2024, the largest contributors to Samsung Biologics's Scope 3 emissions were:a
- Purchased Goods and Services (Cat. 1): 303,852.504 tCOâ‚‚e(67.76%)
- Capital Goods (Cat. 2): 50,200.289 tCOâ‚‚e(11.2%)
- Fuel- and Energy-Related Services (Cat. 3): 36,648.358 tCOâ‚‚e(8.17%)
Samsung Biologics's Scope 3 Emissions by Categories
Insights into Samsung Biologics’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Samsung Biologics reported Scope 1 greenhouse gas (GHG) emissions of 71,971.718 tCOâ‚‚e and total revenues of USD 3,099 millions. This translates into an emissions intensity of 23.22 tCOâ‚‚e per millions USD.a
Samsung Biologics's Scope 1 Emissions Intensity Compared to Peers
How does Samsung Biologics's GHG emissions intensity compare to its peers?
In 2024, Samsung Biologics reported a Scope 1 emissions intensity of 23.22 tCOâ‚‚e per millions USD. Compared to the peer group median of 4.12, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does Samsung Biologics rank on GHG emissions intensity within its industry?
In 2024, Samsung Biologics ranked 22 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places Samsung Biologics among the least efficient performers, with one of the highest emissions intensities in its sector.a
Insights into Samsung Biologics's Total Carbon Footprint
In 2024, Samsung Biologics reported a total carbon footprint of 682,119.226 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 7.01% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Samsung Biologics's total carbon footprint was Scope 3 emissions, accounting for 65.74% of the company's total carbon footprint, followed by Scope 2 emissions at 23.71%.a